Feng M R, Turluck D, Burleigh J, Lister R, Fan C, Middlebrook A, Taylor C, Su T
Pfizer global Research and Development Ann Arbor laboratory, Ann Arbor, MI, USA.
Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):123-8. doi: 10.1007/BF03190385.
Pregabalin [PGB, (S)-3-isobutyl GABA, CI-1008] is a derivative of the inhibitory neurotransmitter g-aminobutyric acid (GABA). It has shown anticonvulsant, analgesia and anxiety activity in animal models. In this report, blood-brain barrier (BBB) influx and efflux of PGB were investigated with microdialysis at efficacious doses in rats. BBB influx (CLin) and efflux (CLout) permeability for pregabalin were 4.8 and 37.2 microL/min/g brain, respectively, following an intravenous infusion to rats. The results indicate that PGB is brain penetrable, supporting its anti-epilepsy and other CNS pharmacology. Significant anticonvulsant action of PGB was detected between 2 and 8 hr post oral dose, which is lag behind ECF drug concentrations lees. A PK/PD link model was used to describe the counter-clockwise hysteresis relationship between pregabalin brain ECF concentration and the anticonvulsant effect in rats. The resulting Ce (concentration in effect compartment) versus effect profile exhibits a sigmoidal curve and the calculated ECe50 and Keo values were 95.3 ng/mL and 0.0092 min-1, respectively. The small Keo value suggests that the effect is not directly proportional to the amount of pregabalin in the ECF compartment possibly due to inherent delay.
普瑞巴林[PGB,(S)-3-异丁基γ-氨基丁酸,CI-1008]是抑制性神经递质γ-氨基丁酸(GABA)的衍生物。它在动物模型中已显示出抗惊厥、镇痛和抗焦虑活性。在本报告中,采用微透析法在大鼠有效剂量下研究了普瑞巴林的血脑屏障(BBB)内流和外流情况。给大鼠静脉注射后,普瑞巴林的BBB内流(CLin)和外流(CLout)渗透率分别为4.8和37.2 μL/min/g脑。结果表明普瑞巴林可穿透血脑屏障,这支持了其抗癫痫及其他中枢神经系统药理学作用。口服给药后2至8小时检测到普瑞巴林有显著的抗惊厥作用,这比细胞外液(ECF)药物浓度的滞后时间要短。采用药代动力学/药效学(PK/PD)连接模型来描述普瑞巴林脑ECF浓度与大鼠抗惊厥作用之间的逆时针滞后关系。由此得到的效应室浓度(Ce)与效应曲线呈S形曲线,计算得到的ECe50和Keo值分别为95.3 ng/mL和0.0092 min-1。较小的Keo值表明效应可能与ECF室中普瑞巴林的量不成正比,这可能是由于存在内在延迟。